Roxana Mehran on Muck Rack

Roxana Mehran

Mount Sinai
As seen in: Nature, heart, The BMJ, JAMA (The Journal of the American Medical Association), JAMA: Journal of the American Medical Association, JAMA Cardiology, Medscape, The Lancet, Eagle's Eye View: Your Weekly CV Update From ACC.org, AHA/ASA Journals and
Interventional Cardiologist, Professor of Medicine, Clinical Trialist, Founder Women As One, Mom
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Roxana

Contact Roxana, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Dual Antiplatelet Therapy Duration in Patients at High Bleeding Risk : A Systematic Review and Meta-Analysis

|
By Andrea Zito, Antonio Landi, Deepak L. Bhatt, Shao-Liang Chen, Giuseppe De Luca, Anna Franzone, Hyeon-Cheol Gwon, Jeehoon Kang, Joo-Yong Hahn, Sung-Jin Hong, Yangsoo Jang, Byeong-Keuk Kim, Hyo-Soo Kim, Takeshi Kimura, Roxana Mehran, Philippe Gabriel Steg, Gregg W. Stone, Pascal Vranckx, Stephan Windecker, Marco Valgimigli, Kyoung-Woo Park
| JAMA Cardiology
Dual Antiplatelet Therapy Duration in Patients at High Bleeding Risk: A Systematic Review and Meta-Analysis Key Points Question Among patients at high bleeding risk (HBR) undergoing percutaneous coronary intervention (PCI), is an abbreviated dual antiplatelet therapy (DAPT) regimen safer and as effective as standard DAPT duration?
Open in Who Shared Issue with article?

Lipoprotein(a) and Women’s Cardiovascular Health: A Review

|
By Erin D. Michos, Stephanie Saucier, Roxana Mehran
| JACC (Journal of the American College of Cardiology)
Sex (ie, to be biologically female) and sociocultural gender (ie, to identify as a woman) have complex and frequently intertwined impacts on CVD risk, CVD manifestation, health care utilization, and CV outcomes.20,21 Multiple factors specific to women may contribute to CVD risk, including premature or late-onset menarche; endometriosis; polycystic ovary syndrome (PCOS); multiparity; use of assisted reproductive technology; miscarriage, gestational diabetes, pre‑eclampsia, and other APOs; and...
Open in Who Shared Issue with article?

Sex-Based Patterns and Trends in Transcatheter Aortic Valve Implantation

|
By Johny Nicolas, Annetine C. Gelijns, Alan J. Moskowitz, Martin Leon, Roxana Mehran, Joanna Chikwe, Michael Mack, Mayra Guerrero, Raj R. Makkar, Mariell Jessup, Patrick O’Gara, Natalia Egorova
| JAMA Cardiology
Key Points Question Among US Medicare beneficiaries, how have sex-specific patterns and outcomes of transcatheter aortic valve implantation (TAVI) evolved from 2013 to 2022? Findings In this cohort study of 314 123 patients, the proportion of women undergoing TAVI declined from 47.6% to 43.6% over 10 years. Although periprocedural mortality and complications decreased substantially in both sexes, women consistently exhibited higher early risk but modestly lower long-term mortality than men.
Open in Who Shared View Duplicates (1) Issue with article?
See all 113 licensed articles (115 Total)
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified